Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Appendicectomy in ulcerative colitis patients with primary sclerosing cholangitis

The effects of appendicectomy in inflammatory bowel disease require further study in order to identify any influence on the extent of colitis, concludes an Australian study in the latest issue of Gut.

News image

fiogf49gjkf04

Appendicectomy, like smoking, is known to influence the clinical behavior of ulcerative colitis. However, in patients with coexistent primary sclerosing cholangitis (PSC), the phenotype of their disease already differs from those patients with ulcerative colitis (UC) alone.

Researchers have therefore examined the interaction of appendicectomy and PSC on the epidemiology and clinical course of ulcerative colitis, to see what further differences may be observed.

Patients from the Brisbane IBS Research Group database were used to carry out the study, with controls taken from the Australian twin registry.

A total of 78 PSC-inflammatory bowel disease (PSC-IBD) patients, 12 pure PSC patients, and 294 UC patients were matched with 1466 controls by sex and birth cohort that comprised randomly selected twins from each twin pair.

Investigations were then carried out into the effects of appendicectomy, smoking, or PSC on various clinical factors.

These were onset of disease, disease extent, disease severity (as identified by immunosuppression-colectomy or liver transplant) and disease related complications. Disease related complications were classed as high grade dysplasia, colorectal cancer, or cholangiocarcinoma.

All investigations were analyzed using univariate and multiple logistic regression analyses.

The researchers found that PSC-IBD patients suffered from more extensive colitis that did UC patients, but required less immunosuppression, a finding which was independent of disease extent.

Furthermore, such patients had an increased likelihood of having high grade dysplasia or colorectal cancer than did UC patients.

Appendicectomy can influence ulcerative colitis
Gut

In the PSC groups there was no difference in appendicectomy rates when compared with the control group.

This contrasted dramatically with the UC patients, who were four times less likely to have undergone appendicectomy than were subjects from the control group.

When examining the affect of appendicectomy, there appeared to be an approximate five year delay in the onset of intestinal (PSC-IBD or UC) or hepatic (PSC) disease in those patients who had undergone prior appendicectomy. This finding was independent of smoking.

However, appendicectomy did not independently alter the extent or severity of disease in PSC.

This was not the case in UC, where prior appendicectomy was associated with more extensive disease but with a lesser requirement for immunosuppression or colectomy for the treatment of colitis.

Non-statistically significant trends for high grade dysplasia or colorectal cancer were identified with appendicectomy in both PSC-IBD and UC. Despite the lack of statistical significance, colorectal cancer appeared more frequent with appendicectomy in a meta-analysis of the available UC data from this and another Australian study.

The researchers conclude that unlike UC, appendicectomy did not significantly influence the prevalence of the PSC groups, or the extent of colitis in PSC-IBD. However, as with UC, appendicectomy did appear to delay their onset.

They add that extensive milder colitis, which is characteristic of PSC-IBD, relates to other poorly understood factors.

Further prospective studies, they say, are required to determine any influence of appendicectomy on the extent of colitis in IBD and an associated dysplasia or colorectal cancer.

Gut 2004; 53(7): 973
30 June 2004

Go to top of page Email this page Email this page to a colleague

 24 May 2018 
Precision medicine for tumors
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 23 May 2018 
High body mass index is and ulcerative colitis
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Fecal incontinence and quality of life in IBD
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us